These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 32766674)
21. Association of Adverse Experiences and Exposure to Violence in Childhood and Adolescence With Inflammatory Burden in Young People. Rasmussen LJH; Moffitt TE; Arseneault L; Danese A; Eugen-Olsen J; Fisher HL; Harrington H; Houts R; Matthews T; Sugden K; Williams B; Caspi A JAMA Pediatr; 2020 Jan; 174(1):38-47. PubMed ID: 31682707 [TBL] [Abstract][Full Text] [Related]
22. Soluble Urokinase Receptor and Chronic Kidney Disease. Hayek SS; Sever S; Ko YA; Trachtman H; Awad M; Wadhwani S; Altintas MM; Wei C; Hotton AL; French AL; Sperling LS; Lerakis S; Quyyumi AA; Reiser J N Engl J Med; 2015 Nov; 373(20):1916-25. PubMed ID: 26539835 [TBL] [Abstract][Full Text] [Related]
23. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus. Toldi G; Szalay B; Bekő G; Bocskai M; Deák M; Kovács L; Vásárhelyi B; Balog A Biomarkers; 2012 Dec; 17(8):758-63. PubMed ID: 23033975 [TBL] [Abstract][Full Text] [Related]
24. Association of Neurocognitive and Physical Function With Gait Speed in Midlife. Rasmussen LJH; Caspi A; Ambler A; Broadbent JM; Cohen HJ; d'Arbeloff T; Elliott M; Hancox RJ; Harrington H; Hogan S; Houts R; Ireland D; Knodt AR; Meredith-Jones K; Morey MC; Morrison L; Poulton R; Ramrakha S; Richmond-Rakerd L; Sison ML; Sneddon K; Thomson WM; Hariri AR; Moffitt TE JAMA Netw Open; 2019 Oct; 2(10):e1913123. PubMed ID: 31603488 [TBL] [Abstract][Full Text] [Related]
25. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis. Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228 [TBL] [Abstract][Full Text] [Related]
26. Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome. Dowsett J; Didriksen M; von Stemann JH; Larsen MH; Thørner LW; Sørensen E; Erikstrup C; Pedersen OB; Hansen MB; Eugen-Olsen J; Banasik K; Ostrowski SR Sci Rep; 2022 Jan; 12(1):1672. PubMed ID: 35102231 [TBL] [Abstract][Full Text] [Related]
29. Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity. Can U; Buyukinan M; Yerlikaya FH Indian J Med Res; 2017 Mar; 145(3):327-333. PubMed ID: 28749394 [TBL] [Abstract][Full Text] [Related]
35. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study. Rasmussen LJ; Knudsen A; Katzenstein TL; Gerstoft J; Obel N; Jørgensen NR; Kronborg G; Benfield T; Kjaer A; Eugen-Olsen J; Lebech AM HIV Med; 2016 May; 17(5):350-7. PubMed ID: 26365671 [TBL] [Abstract][Full Text] [Related]
36. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Edsfeldt A; Nitulescu M; Grufman H; Grönberg C; Persson A; Nilsson M; Persson M; Björkbacka H; Gonçalves I Stroke; 2012 Dec; 43(12):3305-12. PubMed ID: 23150653 [TBL] [Abstract][Full Text] [Related]
37. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission. Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576 [TBL] [Abstract][Full Text] [Related]